Skip to main content
Fortress Biotech, Inc. (FBIO)
NASDAQ: FBIO · Real-Time Price · USD
3.370
+0.030 (0.90%)
At close: Mar 9, 2026, 4:00 PM EDT
3.340
-0.030 (-0.89%)
After-hours: Mar 9, 2026, 7:02 PM EDT

Fortress Biotech Revenue

Fortress Biotech had revenue of $17.63M in the quarter ending September 30, 2025, with 20.52% growth. This brings the company's revenue in the last twelve months to $62.30M, down -23.56% year-over-year. In the year 2024, Fortress Biotech had annual revenue of $57.68M, down -31.76%.

Revenue (ttm)
$62.30M
Revenue Growth
-23.56%
P/S Ratio
1.68
Revenue / Employee
$616,861
Employees
101
Market Cap
104.60M

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 202457.68M-26.84M-31.76%
Dec 31, 202384.51M8.77M11.58%
Dec 31, 202275.74M6.95M10.11%
Dec 31, 202168.79M23.19M50.86%
Dec 31, 202045.60M8.97M24.49%
Dec 31, 2019 Pro Pro Pro
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro
Dec 31, 2016 Pro Pro Pro
Dec 31, 2015 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
Agenus 106.83M
Codexis 52.93M
Seer, Inc. 16.58M
Korro Bio 7.37M
Equillium 4.39M
Coya Therapeutics 3.99M
Precision BioSciences 698.00K
Revenue Rankings

FBIO News

More News